AnalystsJames GordonJames Gordon's Stock Forecasts
AnalystsJames Gordon
Sectors:
Industries:
Analyst Ranking
Top 33%
#1802 out of 5550 analysts
Average Return
+21.7%
Win Rate
90%9 out of 10
Risk vs Reward
Poor
Good
James Gordon's 5 best and worst ratings
| Name / Ticker | Gain/Loss | Entry Price | Exit Price | Period | Rating |
|---|---|---|---|---|---|
Argenx SeARGX | +56.03% | $359.48 | $560.90 | 2024-05-13 - 2025-05-12 | Strong Buy |
Argenx SeARGX | +40.36% | $588.67 | $826.28 | 2024-11-04 - 2025-11-03 | Strong Buy |
Argenx SeARGX | +35.99% | $459.57 | $624.96 | 2023-12-05 - 2024-12-04 | Strong Buy |
Argenx SeARGX | +27.74% | $516.69 | $660.00 | 2024-08-23 - 2025-08-22 | Strong Buy |
Genmab AGMAB | +27.69% | $44.69 | $57.06 | 2026-10-26 - 2026-10-30 | Strong Buy |
James Gordon Analyst Color
Get additional color on James Gordon's coverage of popular stocks
James Gordon's Stock Coverage
| Name / Ticker | No. Ratings | Rating | Price Target | Upside/Downside | Action | Date |
|---|---|---|---|---|---|---|
Genmab AGMAB | 2 | Strong Buy | N/A | N/A | Upgrades | 5 days ago |
Gsk PLCGSK | 1 | Strong Sell | N/A | N/A | Downgrades | 10 months ago |
Argenx SeARGX | 8 | Strong Buy | $1,100.00 | +23.20% | Maintains | a year ago |
Grifols SaGRFS | 1 | Hold | $10.30 | N/A | Maintains | a year ago |
Morphosys AgMOR | 1 | Hold | $24.00 | N/A | Downgrades | 5 years ago |
Kyntra Bio IncKYNB | 1 | Hold | N/A | N/A | Upgrades | 6 years ago |
Shire PLCSHPG | 1 | Hold | $150.00 | N/A | Maintains | 9 years ago |
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.